You just read:

Enteris BioPharma Doses First Woman in Phase 2a Clinical Trial of Ovarest™ (oral leuprolide tablet) for Endometriosis

News provided by

Enteris BioPharma, Inc.

Aug 24, 2017, 08:00 ET